fbpx
November 2, 2021

FDA Approves Asciminib, Drug With Novel Action in CML FDA Approves Asciminib, Drug With Novel Action in CML

Chronic myeloid leukemia (CML) is typically treated with tyrosine kinase inhibitors (TKIs) such as imatinib (Gleevec) and similar agents, but some patients cannot tolerate these drugs, […]
November 1, 2021

FDA Approves Eye Drops for Presbyopia FDA Approves Eye Drops for Presbyopia

The US Food and Drug Administration for the first time has approved an eye drop to treat presbyopia, also known as age-related blurry near vision, in adults. […]
October 29, 2021

FDA Authorizes Pfizer’s COVID-19 Vaccine for Children 5-11 FDA Authorizes Pfizer’s COVID-19 Vaccine for Children 5-11

The US Food and Drug Administration (FDA) has authorized Pfizer’s vaccine for children ages 5 to 11, which means vaccines could be available to school-aged children […]
October 26, 2021

FDA Approves Drugs for Wet AMD, Macular Edema Due to Uveitis FDA Approves Drugs for Wet AMD, Macular Edema Due to Uveitis

Ophthalmologists in the US will soon have more options in their toolkit to manage neovascular age-related macular degeneration (AMD) and macular edema associated with uveitis. Susvimo, […]
October 20, 2021

FDA Authorizes Boosters for Moderna, J&J, Allows Mix-and-Match FDA Authorizes Boosters for Moderna, J&J, Allows Mix-and-Match

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The US Food and Drug Administration (FDA) has authorized booster doses for […]
October 20, 2021

FDA Clears 5-Minute Test for Early Dementia FDA Clears 5-Minute Test for Early Dementia

The US Food and Drug Administration has given marketing clearance to CognICA, an artificial intelligence–powered integrated cognitive assessment for the early detection of dementia. Developed by […]
October 19, 2021

FDA Approves Combo Pill for Severe, Acute Pain FDA Approves Combo Pill for Severe, Acute Pain

The US Food and Drug Administration (FDA) has approved a combination pill containing celecoxib and tramadol (Seglentis) for the treatment of adults with acute pain severe […]
October 18, 2021

FDA OKs New High-Dose Naloxone Product for Opioid Overdose FDA OKs New High-Dose Naloxone Product for Opioid Overdose

The US Food and Drug Administration (FDA) has approved a high-dose naloxone injection product for the emergency treatment of opioid overdose. ZIMHI from Adamis Pharmaceuticals is […]
October 18, 2021

FDA Expands Use of HIV Drug to Young Children FDA Expands Use of HIV Drug to Young Children

The US Food and Drug Administration (FDA) has approved an expanded indication of the antiretroviral medication Biktarvy for younger children living with HIV. The new lower […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0